China represents a strategic priority market for many companies and investors in today’s evolving life sciences industry. Featuring the unique insights of our full-service legal team in China, this site contains valuable resources to assist clients in navigating the legal complexities of market conditions and industry trends within the region. Learn more.
Ropes & Gray has advised Humble Group AB– a Swedish food-tech and FMCG-group supplying the next generation of products that are good for people and the planet – on its up to SEK 1.384 billion acquisition ...
Life sciences licensing partner Hannah England (Freeman) (Boston) was profiled in Law360 as a life sciences MVP. Hannah represented clients in five of the top 15 biopharmaceutical licensing deals of 2020 measured by deal value, according to an analysis published ...
Health care partner Margaux Hall (Washington, D.C.) will lead a case study discussion on “Navigating the Consolidation Within the Payer & PBM Market” at the virtual Managed Markets & Account Management Strategies Conference on November 9. Margaux ...
